Stocks were indicated to open up more than 1% on Tuesday after some recent profit-taking, now that oil prices have started to recover in recent days. Earnings season continues, and investors are at a crossroads. Either stocks rebounded too much from the March lows or the trillions of dollars of stimulus and a gradual reopening of the economy will set the stage for a massive economic recovery after the second quarter. Investors now should be looking at new ideas for how to be best positioned ahead of summer and for the rest of 2020.

24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find some of those new ideas for long-term investors and short-term traders alike. Some analyst reports cover stocks to buy, and others cover stocks to sell or avoid. Consensus analyst target prices are from Refinitiv.

Analysts are still making many upgrades, downgrades, reiterations and initiations ahead of and after key earnings reports. While some are still cutting price targets and earnings estimates for the coming quarters and the year, many are maintaining their prior official ratings. There are even many traditional upgrades and reiterations taking place as though things were close to normal. Remember that no single analyst report should be used as a sole basis for any buying or selling decision.

These are the top analyst calls seen on Tuesday, May 5, 2020.

Adverum Biotechnologies Inc. (NASDAQ: ADVM) was raised to Buy from Hold with a $21 price target (versus a $13.73 prior close) at SunTrust Robinson Humphrey.

Altice USA Inc. (NYSE: ATUS) was downgraded to Market Perform from Outperform at Bernstein.

AppFolio Inc. (NASDAQ: APPF) was downgraded to Underperform from Neutral at D.A. Davidson.

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) was raised to Overweight from Equal Weight and its price target was raised to $7 from $4 at Barclays. Shares closed up 11% at $3.93 ahead of the call and were indicated up about 10% at $4.40 afterward. The prior consensus price target was $7.13.

Booking Holdings Inc. (NASDAQ: BKNG) was maintained with a Buy rating but its price target was cut to $1,750 from $2,000 (versus a $1,413.30 close) at Needham. Its consensus price target was $1,668.04.

Boot Barn Holdings Inc. (NYSE: BOOT) was named as the Zacks Bear of the Day stock. The firm said that shares have plummeted over 60% year to date as investors price out this stock’s potential. Shares last closed at $18.00, with a consensus price target of $25.00.

Cars.com Inc. (NYSE: CARS) was downgraded to Neutral from Buy at B. Riley FBR.

DraftKings Inc. (NASDAQ: DKNG) was started with a Buy rating and a $25 price target (versus a $20.99 close) at Canaccord Genuity.

Electronic Arts Inc. (NASDAQ: EA) was named as the Bull of the Day at Zacks, which said that EA is unquestionably “in the game” during this pandemic. Shares most recently closed at $116.83 and have a consensus price target of $120.00.

Five9 Inc. (NASDAQ: FIVN) was downgraded to Neutral from Buy at Roth Capital. It closed down 4.4% at $95.88 ahead of the call and was indicated down another 7.6% at $88.60 afterward, with an $81.22 consensus price target.

Intuit Inc. (NASDAQ: INTU) was reiterated as Overweight and its price target was raised to $285 from $275 (versus a $267.78 close) at KeyBanc Capital Markets.

Kura Oncology Inc. (NASDAQ: KURA) was started with an Overweight rating and a $24 price target (versus a $14.70 close) at Barclays.

L Brands Inc. (NYSE: LB) was raised to Outperform from Market Perform with a $17 price target (versus a $12.04 close) at BMO Capital Markets. It had a $16.21 consensus price target.

ONEOK Inc. (NYSE: OKE) was downgraded to Neutral from Outperform at Credit Suisse.

Owens & Minor Inc. (NYSE: OMI) was downgraded to Neutral from Outperform at Robert W. Baird

Peloton Interactive Inc. (NASDAQ: PTON) was reiterated as Buy and its price objective was raised to $41 from $36 (versus a $33.90 close) at BofA Securities. The consensus price target was $38.48.

Replimune Group Inc. (NASDAQ: REPL) was started with an Overweight rating and a $21 price target (versus a $15.93 close) at Barclays.

Salesforce.com Inc. (NYSE: CRM) was started with a Sell rating and a $120 price target at Rosenblatt. Shares closed up over 3% at $161.47 ahead of this call and had a $194.38 consensus price target. They were indicated up 0.2% on Tuesday.

Shake Shack Inc. (NYSE: SHAK) was reiterated as Hold but its price target was raised to $55 from $50 (versus a $52.77 close) at SunTrust Robinson Humphrey. Wedbush Securities reiterated its Neutral rating, along with a $50 price target.

TripAdvisor Inc. (NASDAQ: TRIP) was maintained with a Buy rating but its price target was lowered to $26 from $39 (versus an $18.72 close) at Needham.

Tyson Foods Inc. (NYSE: TSN) was down 7.8% at $55.32 after earnings on Monday. BofA Securities downgraded it to Neutral from Buy and cut its price objective to $60 from $70.

Wells Fargo & Co. (NYSE: WFC) was downgraded to Underweight from Neutral with a $25 price target at Atlantic Equities.

Workday Inc. (NASDAQ: WDAY) was started with a Sell rating and a $110 price target at Rosenblatt. The stock closed up 1.2% at$148.47 ahead of the call, with a $175.16 consensus price target.

Y-mAbs Therapeutics Inc. (NASDAQ: YMAB) was started as Overweight with a $44 price target (versus a $33.80 close) at Barclays.

The BofA Securities analysts have a Yield Advantage group of stocks that are outperforming other high dividend shares. We selected five from the list with big dividends and a Buy rating.

Monday’s top analyst upgrades and downgrades included AON, Cognizant Technology Solutions, Dow, PayPal, PG&E, PNC Financial Services, Qualcomm, Shopify, Tesla, Valero Energy, Walt Disney, Wells Fargo and more.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.